Brian T. Bateman, MD

Brigham and Women's Hospital, Division of Pharmacoepidemiology and Pharmacoeconomics

Presentation(s):

• OP-19A - Implication of Maternal Continuous Enrollment on Stillbirth Gestational Age Distributions and Maternal Characteristics in Medicaid Enrollees

  Monday, August 23, 2021
  11:45 AM – 1:30 PM US Eastern Time

• OP-19B - Feasibility of Using Healthcare Utilization Data to Identify Neurodevelopmental Disorders for Transgenerational Pharmacoepidemiology

  Monday, August 23, 2021
  11:45 AM – 1:30 PM US Eastern Time

• OP-19D - Validating an Optimized Live Birth Gestational Age Algorithm in a Nationwide Medicaid Sample and Quantifying the Misclassification of Exposure Due to Estimated Gestational Age

  Monday, August 23, 2021
  11:45 AM – 1:30 PM US Eastern Time

• SP14F - The Use of Type 2 Diabetes Mellitus Medications During Pregnancy in the United States

  Tuesday, August 24, 2021
  5:15 PM – 6:30 PM US Eastern Time

• OP-16A - First Trimester Exposure to Buprenorphine Compared to Methadone for Treatment of Opioid Use Disorders and the Risk of Congenital Malformations

  Wednesday, August 25, 2021
  11:45 AM – 1:30 PM US Eastern Time

• OP-16C - Prescription Opioid Type and the Risk of Neonatal Opioid Withdrawal Syndrome

  Wednesday, August 25, 2021
  11:45 AM – 1:30 PM US Eastern Time

• OP-16E - Comparative Safety of In-utero Exposure to Buprenorphine Combined with Naloxone versus Buprenorphine Monoproduct with Respect to Congenital Malformations

  Wednesday, August 25, 2021
  11:45 AM – 1:30 PM US Eastern Time

• OP-21B - The Comparative Safety of Antiseizure Medication Polytherapy versus Valproate in Pregnancy and Risk of Major Congenital Malformations

  Wednesday, August 25, 2021
  3:00 PM – 4:30 PM US Eastern Time

• OP-21C - Antidepressant Use During Pregnancy and the Risk of Neurodevelopmental Disorders in Children

  Wednesday, August 25, 2021
  3:00 PM – 4:30 PM US Eastern Time

• OP-21D - The Impact of In-utero Antipsychotic Drug Exposure on Congenital Malformations: An International Cohort Study

  Wednesday, August 25, 2021
  3:00 PM – 4:30 PM US Eastern Time

• OP-21F - The Impact of In-utero Antipsychotic Exposure on Neurodevelopmental Disorders in Children

  Wednesday, August 25, 2021
  3:00 PM – 4:30 PM US Eastern Time

• OP-17C - The Role of Propensity Score Matching in Claims-based Studies for Achieving Comparability in hba1c Levels Between Treatments in Pregnant Women with Type 2 Diabetes

  Wednesday, August 25, 2021
  4:30 PM – 6:00 PM US Eastern Time

• OP-17D - Balance of Unmeasured Covariates After Propensity Score Matching Based on Measurable Covariates in Perinatal Pharmacoepidemiologic Studies

  Wednesday, August 25, 2021
  4:30 PM – 6:00 PM US Eastern Time